---
title: Multicenter Retrospective Study on Streptobacillus Moniliformis Infections in France
nct_id: NCT06711861
overall_status: RECRUITING
sponsor: University Hospital, Strasbourg, France
study_type: OBSERVATIONAL
primary_condition: Streptobacillus Moniliformis Infections
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06711861.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06711861"
ct_last_update_post_date: 2024-12-02
last_seen_at: "2026-05-12T06:17:10.785Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Multicenter Retrospective Study on Streptobacillus Moniliformis Infections in France

**NCT ID:** [NCT06711861](https://clinicaltrials.gov/study/NCT06711861)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 20
- **Lead Sponsor:** University Hospital, Strasbourg, France
- **Conditions:** Streptobacillus Moniliformis Infections
- **Start Date:** 2024-02-16
- **Completion Date:** 2025-02-16
- **CT.gov Last Update:** 2024-12-02

## Brief Summary

French data on Streptobacillus moniliformis infections (zoonosis transmitted by rat bites) are rare and there are no case series in the literature to date. This is a pathology presenting atypical clinical manifestations for a bacterial infection and which therefore remains underdiagnosed. Streptobacillus moniliformis infections can be fatal without appropriate antibiotic treatment. This study could improve diagnosis, develop early treatment strategies and contribute to the overall understanding of zoonotic diseases

## Eligibility

- **Minimum age:** 1 Year
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Minor patient aged 1 to 17 years
* Adult patient ≥18 years
* Proven Streptobacillus moniliformis infection between 01/01/2007 and 31/12/2023
* Subject not objecting, after being informed, to the reuse of their data for the purposes of this research
* Holders of parental authority not objecting, after being informed, to the reuse of their data for the purposes of this research their child for the purposes of this research

Exclusion Criteria:

* Subject and/or holder of parental authority having expressed opposition to participating in the study
```

## Primary Outcomes

- **Retrospective study of the effectiveness of antibiotic therapy initiated for the treatment of Streptobacillus moniliformis infection.** _(time frame: Negative blood culture 15 days after the start of antibiotic therapy.)_ — Clinical cure 15 days after the start of antibiotic therapy. This cure is based on a negative blood culture (absence of germs) performed 15 days after the start of treatment.

## Locations (1)

- Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France, Strasbourg, France — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.service des maladies infectieuses et tropicales - chu de strasbourg - france|strasbourg||france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06711861.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06711861*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*